Chinese Journal of Dermatology ›› 2015, Vol. 48 ›› Issue (4): 233-236.

Previous Articles     Next Articles

Efficacy of 308-nm excimer laser combined with tazarotene gel for the treatment of plaque psoriasis

  

  • Received:2014-08-22 Revised:2014-12-18 Online:2015-04-15 Published:2015-03-27

Abstract:

Tang Zhiming, Zhai Xiaoxiang, Jing Mengqing. Department of Dermatology, Traditional Chinese Medicine Hospital of Xuzhou City, Xuzhou 221003, Jiangsu, China Corresponding author: Tang Zhiming, Email: 158914788@qq.com 【Abstract】 Objective To investigate the clinical efficacy and safety of 308-nm excimer laser combined with tazarotene gel for the treatment of plaque psoriasis. Methods Seventy-two patients with plaque psoriasis were randomly and equally divided into three groups according to a random number table: tazarotene group topically applying tazarotene gel once per night, 308-nm excimer laser group treated with 308-nm excimer laser, combination group treated with both tazarotene gel and 308-nm excimer laser. Clinical efficacy was evaluated according to psoriasis area and severity index (PASI) score and response rate, and safety according to adverse reactions at week 2, 4 and 8 after starting treatment. Results PASI score was significantly lower in the combination group at week 4 and 8 (4.75 ± 0.44 and 2.35 ± 0.37 respectively) than in the 308-nm excimer laser group (6.75 ± 0.57 and 4.67 ± 0.36 respectively, both P < 0.05) and tazarotene group (8.75 ± 0.48 and 6.48 ± 0.45 respectively, both P < 0.05), and significantly lower in the combination group at week 8 than at week 2 and 4 (both P < 0.05). A significant increase was observed in the response rate at week 2, 4, and 8 in the combination group (29.1% (7/24), 66.7% (16/24) and 87.5% (21/24) respectively) compared with the tazarotene group (12.5% (3/24), 41.7% (10/24) and 62.5% (15/24) respectively, all P < 0.05) and 308-nm excimer laser group (20.8% (5/24), 50.0% (12/24) and 75.0% (18/24) respectively, all P < 0.05). No systemic adverse reactions were observed in any of the 3 groups during the study, and there was no significant difference in the incidence of local adverse reactions between the combination group, tazarotene group and 308-nm excimer laser group (16.7% (4/24) vs. 12.5% (3/24) vs. 12.5% (3/24), P > 0.05). Conclusion The efficacy of 308-nm excimer laser combined with tazarotene gel is superior to that of tazarotene gel or 308-nm excimer laser alone in the treatment of plaque psoriasis.